On the other hand, patients with acute coronary syndromes (ACS) were examined to assess the role of vascular inflammation and biomarkers, specifically sLOX-1, in the development and complexity of coronary artery disease (CAD). This evidence concerns the gene OLR1 and coronary artery disorder.